Author:
Miyata Satsuki,Tominaga Kaoru,Sakashita Eiji,Urabe Masashi,Onuki Yoshiyuki,Gomi Akira,Yamaguchi Takashi,Mieno Makiko,Mizukami Hiroaki,Kume Akihiro,Ozawa Keiya,Watanabe Eiju,Kawai Kensuke,Endo Hitoshi
Funder
Jichi Medical University
MEXT | Japan Society for the Promotion of Science
This research was supported by the FY2011 Grand Prize for Promotion of Human Metabolome Technologies Metabolomics Cutting Edge Research.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Dolecek, T. A., Propp, J. M., Stroup, N. E. & Kruchko, C. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005–2009. Neuro Oncol. 14, v1–v49 (2012).
2. Comittee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (2001–2004). 13th ed. Neurol. Med. Chir. (Tokyo) 54(Suppl), 1–102 (2014).
3. Wilson, C. B. Glioblastoma: the past, the present, and the future. Clin. Neurosurg. 38, 32–48 (1992).
4. Pellegatta, S., Cuppini, L. & Finocchiaro, G. Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas. Expert Rev. Anticancer Ther. 11, 1759–1774 (2011).
5. Khasraw, M., Simeonovic, M. & Grommes, C. Bevacizumab for the treatment of high-grade glioma. Expert Opin. Biol. Ther. 12, 1101–1111 (2012).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献